Carregant...
Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
In atrial fibrillation (AF), oral anticoagulant (OAC) therapy with either vitamin K antagonist or non–vitamin K antagonist is used to prevent thromboembolic complications. In patients who presented with acute coronary syndrome (ACS) and were treated by percutaneous coronary intervention (PCI), dual...
Guardat en:
Publicat a: | Int J Angiol |
---|---|
Autor principal: | |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Thieme Medical Publishers
2020
|
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250634/ https://ncbi.nlm.nih.gov/pubmed/32476809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1702208 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|